Trials / Active Not Recruiting
Active Not RecruitingNCT04245176
Genetic Testing for All Breast Cancer Patients (GET FACTS)
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 400 (actual)
- Sponsor
- Dana-Farber Cancer Institute · Academic / Other
- Sex
- All
- Age
- 18 Years – 79 Years
- Healthy volunteers
- Not accepted
Summary
This study is designed to determine the impact of a novel genetic counseling method on surgical decisions in individuals with newly diagnosed breast cancer This research study involves an expedited and surgery-specific form of genetic counseling. The names of the study methods involved in this trial are/is: * Quantitative genetic counseling (discussion is guided by tables and graphs) * Standard genetic counseling
Detailed description
* The research study procedures include screening for eligibility and study interventions including evaluations and follow up visits * After receiving genetic testing, participants will be placed into one of two counseling methodology groups: * Standard genetic counseling: Standard of care discussion * Quantitative genetic counseling: Discussion is guided by tables and graphs. * Participants will be on the research study for up to six months, with an optional extension to two years. * It is expected that about 450 people will participate. * This research study is a Feasibility Study, which is the first-time investigators are examining this form of genetic counseling. * This is a randomized study. Randomization means being put into a group by chance. It is like flipping a coin. Neither the participant nor the Investigator will choose the group the participant is assigned to.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Standard Genetic Counseling | Standard genetic counseling: Standard of care discussion |
| BEHAVIORAL | Quantitative Genetic Counseling | Quantitative genetic counseling: Discussion is guided by tables and graphs. |
Timeline
- Start date
- 2020-01-31
- Primary completion
- 2025-12-01
- Completion
- 2025-12-01
- First posted
- 2020-01-28
- Last updated
- 2025-03-05
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04245176. Inclusion in this directory is not an endorsement.